Vimpat and Lactose intolerance - a phase IV clinical study of FDA data
Lactose intolerance is reported only by a few people who take Vimpat.
The phase IV clinical study analyzes which people take Vimpat and have Lactose intolerance. It is created by eHealthMe based on reports of 14,836 people who have side effects while taking Vimpat from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
14,836 people reported to have side effects when taking Vimpat.
Among them, 2 people (0.01%) have Lactose intolerance.
What is Vimpat?
Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 15,329 Vimpat users for its effectiveness, alternative drugs and more.
What is Lactose intolerance?
Lactose intolerance (inability to digest lactose) is found to be associated with 1,186 drugs and 929 conditions by eHealthMe.
Number of Vimpat and Lactose intolerance reports submitted per year:
Gender of people who have Lactose intolerance when taking Vimpat *:
- female: 100 %
- male: 0.0 %
Common drugs people take besides Vimpat *:
- Zonegran: 1 person, 50.00%
- Zofran: 1 person, 50.00%
- Carafate: 1 person, 50.00%
- Claritin: 1 person, 50.00%
- Crestor: 1 person, 50.00%
- Detrol: 1 person, 50.00%
- Dilaudid: 1 person, 50.00%
- Epidiolex: 1 person, 50.00%
- Humalog: 1 person, 50.00%
- Imodium A-D: 1 person, 50.00%
Common side effects people have besides Lactose intolerance *:
- Weight Increased: 1 person, 50.00%
- Rash Pruritic (redness with itching): 1 person, 50.00%
Common conditions people have *:
- Tooth Disorder (tooth disease): 1 person, 50.00%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Vimpat and have Lactose intolerance?Check whether Lactose intolerance is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Vimpat:
- Vimpat (15,329 reports)
Lactose intolerance treatments and more:
- Lactose intolerance (3,104 reports)
COVID vaccines that are related to Lactose intolerance:
- Lactose intolerance in Moderna COVID Vaccine
- Lactose intolerance in Pfizer BioNTech Covid Vaccine
- Lactose intolerance in Johnson and Johnson Covid Vaccine
How severe was Lactose intolerance and when was it recovered:
Expand to all the drugs that have ingredients of lacosamide:
Common drugs associated with Lactose intolerance:
- Aspirin: 212 reports
- Benicar: 117 reports
- Fosamax: 117 reports
- Humira: 107 reports
- Omeprazole: 128 reports
- Prednisone: 129 reports
- Revlimid: 240 reports
- Synthroid: 196 reports
- Tylenol: 106 reports
- Vitamin d: 103 reports
All the drugs that are associated with Lactose intolerance:
- Lactose intolerance (1,186 drugs)
Common conditions associated with Lactose intolerance:
All the conditions that are associated with Lactose intolerance:
- Lactose intolerance (929 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lacosamide (the active ingredients of Vimpat) and Vimpat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.